Running a Fortune 500 company as its CEO is arguably much more complex than piloting a Boeing 787 Dreamliner or an F-16 Jet for that matter. Enter the cockpit of a fighter plane and you will be amazed by the myriad arrays of display panels and complex control systems. I have been talking to multiple customers in various industries and the sentiment is same across all the customer segments. Industry executives that I have talked to echo in unison that “Embracing Innovation” is a key pain point for today’s CEO as the organizations become more and more complex due to interdependencies with a number of moving parts and the interactions of these moving parts often lead to unpredictable outcomes. Innovation is one key enabler that will help break down the complexity barrier and helps simplify the internal workings of an organization as well as its relationships with its customers. Innovation can play a key role in making things easier and simpler starting from the internal business processes to the customer and supplier facing processes as well as in launching ground breaking products and solutions for the end customers thus helping the firm remain ahead of the curve.
Companies world over pare down their Innovation and R&D Budgets in times of poor global macro-economic conditions and try to improve their bottom-line thus getting inextricably caught into what is called as an “Acceleration Trap”. Many firms across the world fare very poorly when it comes to explaining the investments in “Innovation” to the bourses and more often than not get beaten up on their stock prices. Innovation needs a long term approach and “Incubations” by their very definition need a reasonable gestation period. Firms need to adopt a portfolio or a venture capitalist mindset in their approach to innovations. All the innovation investments may not lead to successful product launches and similarly the entire R&D endeavors may not see light at the end of the tunnel. However if the probability of failure is encapsulated in the ‘innovation portfolio’ model then one will start looking at the entire concept of innovation in a different light. None know this better than the pharmaceutical companies who invest large amounts on innovation on a basket of initiatives hoping that atleast one will become a blockbuster hit.
The board rooms of Fortune 500 companies are now abuzz with the term, “Reverse Innovation” and are looking at ways to leverage its potential to aid the growth of the firm. Now-a-days the mantra is to carry out focused R&D efforts targeted at creating products that are specially designed and adapted to the emerging economies. The needs of the emerging markets are different and so are the price points and value expectations of the consumers in the emerging markets. The approach mentioned above needs innovations and inventions in core technology areas such as material sciences, electronics, fluid mechanics, power systems and the like. Consider the example of the Nano car developed by TATA motors which needed multiple inventions/innovations in technology and also needed cross functional teams working on different engineering disciplines to come together to solve complex issues and provide solutions while at the same time meeting the targeted price point.
“Reverse Innovation” is about the products designed for emerging economies being taken back to the developed economies and positioned there as ‘value for money’ products. This shifts the center of gravity where in the products once designed for advanced economies were stripped down and sold in developing economies whereas now the innovations made by MNCs in the emerging markets are taken back home to the advanced economies and positioned as ‘more for less’ products.
The Fortune 500 companies can now adopt a mix of ‘Innovation’ and ‘Reverse Innovation’ strategies to cater to the needs of a wider audience in their home countries as well as in the emerging economies. This will become a significant competitive advantage for these firms and help increase their top-line/bottom-line and thus the market capitalization. Let me try to illustrate the example of how this can work for say a mobile telephony operator which operates in both US and in India. In US the strategy of the CSP will be to harness the high speed data and broadband services to capture the markets from higher spending customers such as those using smart phones and tablets extensively for their day to day work. This will be possible due to the eco system of app providers, CSPs, high end customers and app developers. However if the same CSP has to operate in India where the voice till accounts for a majority of its revenues and where most of the customers still use ‘feature phones’ with basic features it has to carry out reverse innovation. To increase its data traffic in the absence of a large smart phone base it has to develop easy to use apps that can work on feature phones using just a basic browser or via simple apps that work on the top of the SMS technology. What is taken for granted in the advanced countries like the QoS and extent of network coverage are still largely absent in emerging markets. Some of the banks that have rolled out a Financial Inclusion programs on top of the mobile technology have had to work out options where in the customer can work offline and the sync up happens when he enters the areas where there is network coverage. Similar innovations can be exported to advanced countries for providing services to customers in the areas where the network coverage is weak or for customers who cannot afford smart phones.
The other key area that can be a part of the corporate strategy are the ‘bottom of the pyramid’ customers not necessarily those in developing nations but the ones who are relatively at the bottom of the pyramid in the advanced nations. This is the group of customers whose needs would be similar to those in emerging economies and thus would more than welcome the ‘value for money’ offered via ‘reverse innovation’ mechanisms.
When comparing the performance of the firms in the markets, we need to lay specific emphasis on the “net value creation” to the shareholders in dollar terms and not worry too much about the growth rate or the profitability % in isolation. The market value is based on the net present value of the anticipated future value creation to the shareholders over a longer time horizon which is function of both the growth rate and profitability. However in the recent past the emphasis has become way too much on the quarterly performance of the firm. This nature of the markets places a lower premium on the firms that invest money on Innovations and R&D and in many a case tends to punish the firm by under valuating it. The CEO of the firm needs to master the art and science of “communicating” the strategic intent and be able to exude confidence to the markets about the ROI and long term impact from the investments being made in areas related to innovation.
The strategy outlined above where in the combination of innovation and reverse innovation are used hand in hand is a win-win strategy for the global firm which has operations in advanced countries as well as in emerging markets and also has the double benefit of tapping the BOP potential in the advanced countries. Also the firms need to take a pause and convince share-holders to take a middle term view of the situation say like financial performance in 5 years from now rather than taking the short term or long term view of things.